Tandem Diabetes Care Inc TNDM

Morningstar Rating
$16.50 0.00 (0.00%)
View Full Chart

Company Report

Tandem Poised to Launch Tubeless Mobi Pump

Though Tandem Diabetes has made a splash in the insulin pump market as the most recent entrant in the US, the firm is still endeavoring to establish itself as a major competitor. On this rather lengthy path between the initial 2012 launch of its original t:slim pump and consistent positive earnings from operations, Tandem still has a number of years to go, from our perspective.

Price vs Fair Value

TNDM is trading at a LOCK|^P%>n premium.
Price
$16.49
Fair Value
P&>
Uncertainty
LOCK|h& >q^w
1-Star Price
^<w
5-Star Price
>G&
Economic Moat
LOCK|HZ%
Capital Allocation
LOCK|K!QpCZ>

Bulls Say, Bears Say

Bulls

Tandem’s t:slim X2 features a low-profile, color touchscreen that is very user-friendly for patients new to insulin pumps.

Bears

MiniMed arguably enjoys more accurate and advanced algorithms thanks to its far larger patient user base and proprietary data—a major reason why it remains a step ahead of Tandem in closing the loop.

News

Articles & Videos

Trading Information

Previous Close Price
$16.50
Day Range
$16.27–17.35
52-Week Range
$12.26–29.65
Bid/Ask
$16.50 / $17.27
Shares Outstanding
69.58M
Market Cap
$1.15B
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.08
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
2,500

Competitors

Valuation

Metric
TNDM
PODD
DXCM
Price/Earnings (Normalized)
—22.2833.80
Price/Book Value
8.806.3812.41
Price/Sales
1.083.066.90
Price/Cash Flow
19.1915.1522.10
Price/Earnings
TNDM
PODD
DXCM

Financial Strength

Metric
TNDM
PODD
DXCM
Quick Ratio
2.441.511.37
Current Ratio
3.182.481.73
Interest Coverage
−9.299.0480.16
Quick Ratio
TNDM
PODD
DXCM

Profitability

Metric
TNDM
PODD
DXCM
Return on Assets (Normalized)
−0.60%13.00%14.49%
Return on Equity (Normalized)
−4.33%29.07%36.44%
Return on Invested Capital (Normalized)
−1.23%17.78%20.31%
Return on Assets
TNDM
PODD
DXCM

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|wq^B?%&LOCK|#g%&^$167B
Medtronic PLC
MDT
LOCK|r@l>#tLOCK|@c$%G$111B
Stryker Corp
SYK
LOCK|K@lT%bkLOCK|#Dt$105B
Boston Scientific Corp
BSX
LOCK|F<$bRyLOCK|W&<$$63B
Edwards Lifesciences Corp
EW
LOCK|@&@Kf>B>LOCK|GWh?$49B
DexCom Inc
DXCM
LOCK|$&>!%$NGLOCK|%>&$$33B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|FjV$>jLOCK|!^$29B
Koninklijke Philips NV ADR
PHG
LOCK|?vLOCK|r<$23B
Steris PLC
STE
LOCK|HGKlH>JLOCK|^x@^#$20B
Zimmer Biomet Holdings Inc
ZBH
LOCK|PyB&#dPLOCK|ym$17B

Sponsor Center